Role of mental disorders in nosocomial infections after hip fracture treatment.

The association between mental disorders (MDs) and iatrogenic complications after hip fracture surgery has been poorly studied. Among iatrogenic complications, nosocomial infections (NIs) are a major factor in hip fracture surgery. The aim of this paper was to determine whether patients with a MD and a hip fracture develop more NIs after hip surgery than patients with no MD. We studied 912 patients who underwent surgery for a hip fracture (223 patients with a MD who underwent surgery for a hip fracture and 689 control patients without a MD who also underwent surgery for a hip fracture) and followed them after surgery. Univariable and multivariable analyses were performed using simple and multiple logistic regression analysis (confidence interval, crude and adjusted odds ratios, and P value). We found that MDs, gender, and comorbidities were not associated with a higher risk of developing a NI after surgery for a hip fracture. Only age increases the risk of a NI.

Fractura de cadera : proceso asistencial integrado

Este proceso asistencial reemplaza al anterior "Fractura de cadera en el anciano", publicado en 2002 (http://www.repositoriosalud.es/handle/10668/1533). Publicado en la página web de la Consejería de Igualdad, Salud y Políticas Sociales: www.juntadeandalucia.es/salud (Consejería de Igualdad, Salud y Políticas Sociales/ Profesionales / Nuestro Compromiso por la Calidad / Procesos Asistenciales Integrados)

Fracturas inestables de radio distal. Nuestra experiencia en osteosíntesis con placa volar de ángulo variable

OBJECTIVE: assess the functional, subjective and radiological results obtained in patients treated with variable-angle locking plate for unstable distal radius fracture and compare these results with current studies. PATIENTS AND METHOD: From October of 2008 to July of 2011, 20 patients were included who had undergone intervention using the volar approach to the Flexor Carpi Radialis. The average follow up was 18 months. Both clinical and radiological results were analyzed. The Mayo Wrist Score and DASH questioner were used. RESULTS: The average age was 50 years; 50% men and 50% women. The consolidation of the fracture was verified in all cases. An average volar angle was obtained of 5º, radial inclination of 19º, radial height of 10.5 mm, and ulnar variance of -1 mm. The clinical assessment revealed an average dorsal flexion of 75º, palm flexion of 70º, supination of 75º and pronation of 73 º. The results for the DASH questionnaire showed an average of 17.8 and 82.7 for the Mayo Wrist Score. CONCLUSIONS: Our experience has provided some good results, both in functional and subjective as well as radio logical terms, similar to those found in studies with implants from the same generation.

¿Es posible tratar una fractura supraintercondilea de codo por artroscopia?

This paper presents a new approach to the treatment of acute fractures in the elbow area, with the support of arthroscopic equipment. There are only a few studies that describe the indications, techniques and results of the arthroscopy-assisted treatment of these pathologies. The authors believe that this tool can be useful for achieving a precise definition of the type of bone-ligament injuries in an elbow joint, thus optimizing treatment and supporting early functional recovery.

Variació segons edat i sexe del component força de l'escala de Constant de valoració de la funció de l’espatlla

Un dels instruments més utilitzats per a mesurar la funció de l’espatlla és el conegut com a Constant Score on una quarta part del valor total de la valoració funcional de l’espatlla correspon a la força d’aquesta regió anatòmica. En el disseny original del Constant Score no es tingueren en compte les possibles variacions dels valors normals de força en funció de l’edat o del sexe. Aquesta variació no ha estat mai correctament establerta. Aquest treball pretén establir l’existència de diferències en la força de l’espatlla entre diferents grups d’edat i entre sexes.

Tibio-talar arthrodesis with long anterograde nail after complex open fracture-dislocation of the ankle : P17

Introduction: Posttraumatic painful osteoarthritis of the ankle joint after fracture-dislocation often has to be treated with arthrodesis. In the presence of major soft tissue lesions and important bone loss the technique to achieve arthrodesis has to be well chosen in order to prevent hardware failure, infection of bulky implants or non-union. Methods: We present the case of a 53 year-old biker suffering of a fracture-dislocation of the ankle associated with a mayor degloving injury of the heel. After initial immobilization of the lesion by external fixation in Spain the patient was transferred to our hospital for further treatment. The degloving injury of the heel with MRSA infection was initially treated by repeated débridement, changing of the configuration of the Ex Fix and antibiotic therapy with favourable outcome. Because of the bony lesions reconstruction of the ankle-joint was juged not to be an option and arthrodesis was planned. Due to bad soft-tissue situation standard open fixtion with plate and/or screws was not wanted but an option for intramedullary nailing was taken. However the use of a standard retrograde arthrodesis nail comes with two problems: 1) Risk of infection of the heel-part of the calaneus/nail in an unstable soft tissue situation with protruding nail. And 2) talo-calcaneal arthrodesis of an initially healthy subtalar joint. Given the situation of an unstable plantar/heel flap it was decided to perform anklearthrodesis by means of an anterograde nail with static fixation in the talus and in the proximal tibia. Results:This operation was performed with minimal opening at the ankle-site in order to remove the remaining cartilage and improve direct bone to bone contact. Arthrodesis was achieved by means of an anterograde T2 Stryker tibial nail.One year after the anterograde nailing the patient walks without pain for up to 4 hours with a heel of good quality and arthrodesis is achieved. Conclusion: Tibiotalar arthrodesis in the presence of mayor soft tissue lesions and bone loss can be successfully achieved with antegrade nailing.

Eficacia del hierro endovenoso en los pacientes añosos con fractura de cadera

Como parte del proyecto A.P.A.T. (Asistencia y seguimiento al Paciente Anciano Traumatizado), desarrollamos un protocolo para optimizar la hemoglobina preoperatoria mediante ferroterapia endovenosa, en pacientes con fractura de cadera susceptible de intervención quirúrgica. Los objetivos del estudio fueron describir el perfil anémico de estos pacientes y determinar la influencia de la administración de hierro endovenoso sobre la transfusión de sangre alogénica (TSA), el número total de concentrados de hematíes administrados y la estancia media hospitalaria.

El paciente Nonagenario con Fractura de fémur

Introducción: Los nonagenarios son un grupo aún reducido, pero en expansión, se estima que en el año 2050 la población anciana en España alcance el 35,7% de la población, aumentando así su importancia relativa y planteando un importante desafío de salud pública Ellos tienen varias particularidades que hay que considerar para planificar futuras estrategias de atención especialmente en el acto quirúrgico dentro del que se calcula que el 3% requerirá en este periodo de vida una intervención quirúrgica por fractura de fémur. Objetivo: Realizamos un estudio retrospectivo de una serie de casos en el que se comparan características de pacientes nonagenarios que requieren intervención quirúrgica por fractura de fémur con un grupo de pacientes octogenarios sometidos a la misma intervención Métodos: Estudio retrospectivo de 100 pacientes programados para cirugía por fractura de fémur en HSCSP, distribuidos en dos grupos de edad grupo 1 mayores o igual a 90 años y grupo 2 ancianos menores o igual de 89 años en el que se recogen datos preoperatorios, intraoperatorios y postoperatorios Resultados: Se incluyeron 100 pacientes divididos en dos grupos, grupo 1 n:50 pacientes mayores de 90 años con un 72% de mujeres, y un promedio de edad de 93.3 años, el grupo 2 n:50 pacientes con edad entre 80 y 89 años con un promedio de 81.1 años de los cuales 78% fueron mujeres y 22% hombres, las patologías más frecuentes en los dos grupos en el momento del preoperatorio fueron HTA 71%, Dislipemia 27% y demencia en un 24%, el 54% de los pacientes nonagenarios fueron clasificados como ASA III, mientras que el grupo 2 el mayor porcentaje (38%) fue ASA IV, El grupo 1 fue intervenido quirúrgicamente en promedio a los 3.12 días del ingreso, el grupo 2 a los 6.9 días, en total promedio de estancia hospitalaria fueron 11.3 días en los pacientes nonagenarios y 15.8 en los pacientes menores de 89 años. Respecto a la mortalidad a 1 mes no hay diferencias entre los dos grupos. Conclusiones Los pacientes mayores de 90 años clasificados como ASA II-III, serán siempre considerados como candidatos a procedimientos quirúrgicos dado que no presentan mayor comorbilidad que pacientes menores y la edad como único factor no es un factor excluyente para la intervención quirúrgica.

Fracturas de escafoides carpiano: estudio retrospectivo en fracturas de polo proximal

Con el objetivo de evaluar los resultados obtenidos en nuestra experiencia con las fracturas de polo proximal de escafoides carpiano nos dispusimos a analizar una serie de variables para constatar los resultados finales en estas fracturas, detectar fallos en nuestros protocolos de actuación y plantear puntos de mejora en su diagnóstico y tratamiento. Para ello se recogieron todos los pacientes diagnosticados de fractura de polo proximal de escafoides entre 2001 y 2007 y de entre ellos analizamos los resultados de aquellos que se intervinieron quirúrgicamente (n=20). Esto incluía tanto aquellos pacientes que presentaban fracturas agudas, así como las pseudoartrosis y los retrasos de consolidación.

Fracturas de astrágalo

Estudio retrospectivo de 63 fracturas de astrágalo recogidas durante un periodo de 13 años. De las 31 fracturas del cuello astragalino se obtuvo un seguimiento de 2 años en 23 de ellas, pudiéndose valorar la aparición en la radiología del signo de Hawkins entre la 6ª y 8ª semana después del traumatismo y el desarrollo o no de necrosis avascular. Se concluye con el estudio que la observación del signo de Hawkins garantiza la correcta perfusión del astrágalo (sensibilidad del 100%). Sin embargo, la no detección de dicho signo no es predictiva del desarrollo de necrosis.

Morbimortalidad Asociada A La Fractura De Cadera Del Paciente Anciano. Analisis De Nuestro Medio

La fractura de cadera es una patología prevalente en la población anciana, con un crecimiento exponencial, altas tasas de morbimortalidad asociada, implicaciones en la calidad de vida y consumo de recursos sanitarios. Objetivos: Conocer las variables epidemiológicas de esta patología, el impacto en la atención médica y el proceso que implica para la adecuada previsión de recursos. Describir las causas de demora quirúrgica y sus posibles consecuencias, e implicaciones de todo lo anterior en la práctica anestésica. Material y métodos: Se realizó un estudio observacional retrospectivo, se revisan pacientes mayores de 65 años con diagnostico de fractura de cadera intervenidos en nuestro hospital entre enero de 2007 y diciembre de 2008, analizando datos epidemiológicos generales, morbimortalidad, antiagregación/anticoagulación, tipo de anestesia y complicaciones, tasa transfusional, estancia hospitalaria, demora quirúrgica y mortalidad, entre otros. Conclusiones: La fractura de cadera es un problema de salud serio y global, con implicaciones importantes en nuestra práctica diaria, en los costos inmediatos y a largo plazo. Siendo responsable de una alta morbimortalidad precoz y tardía. La demora quirúrgica se asocia a un aumento de complicaciones postoperatorias y mortalidad.

Epidemiologia de la fractura a l’atenció primària de catalunya

Utilitzant una base de dades amb informació clínica extreta de l’historial d’Atenció Primària (AP) a Catalunya, hem portat a terme un estudi de cohorts retrospectiu l’any 2009, incloent individus  50 anys. Hem identificat les fractures osteoporòtiques majors utilitzant codis CIE-10. 2.011.430 individus van ser inclosos. La incidència total va ser de 10’91/1.000 persones-any. La fractura més freqüent entre les dones va ser la d’avantbraç i entre els homes la vertebral simptomàtica. Totes les fractures van augmentar amb l’edat però es van observar diferents patrons segons localització. Aquesta informació és rellevant per la planificació dels serveis d’AP al nostre país.

Comparative review of vertebroplasty and kyphoplasty.

The aim of this review is to compare the effectiveness of percutaneous vertebroplasty and kyphoplasty to treat pain and improve functional outcome from vertebral fractures secondary to osteoporosis and tumor conditions. In 2009, two open randomized controlled trials published in the New England Journal of Medicine questioned the value of vertebroplasty in treating vertebral compression fractures. Nevertheless, the practice of physicians treating these conditions has barely changed. The objective of this review is to try to clarify the most important issues, based on our own experience and the reported evidence about both techniques, and to guide towards the most appropriate choice of treatment of vertebral fractures, although many questions still remain unanswered.

Freedom Trial First-Year Extension: Results from 4 Years of Denosumab Exposure in Women with Postmenopausal Osteoporosis

Aims: To investigate the long-term efficacy and safety of denosumab (DMAb) for the treatment of postmenopausal women with osteoporosis in an open-label extension to the 3-year FREEDOM study.1Methods: All women who completed the FREEDOM study were eligible to enter a long-term open-label extension (up to 10 years). After providing informed consent, participants received 6-monthly subcutaneous injections of DMAb (60 mg). Here we report data from the first year of followup. For women randomized to DMAb in the FREEDOM study ('long-term group'), this represents up to 48 months of DMAb exposure (eight 6-monthly injections). For those randomized to placebo ('de novo group') the data are from up to 12 months of exposure (two injections). All participants continued to take calcium (1 g) and vitamin D (≥400 IU) supplements daily. Changes in bone mineral density (BMD) and bone turnover markers (BTM) are reported for subjects enrolled in the extension. No formal statistical testing was planned for this interim report. P-values are descriptive.Results: Overall, 4,550 eligible women (70.2%) who completed the FREEDOM study entered the open-label extension study (long-term, n=2,343; de novo, n=2,207). During the first year of the extension, lumbar spine (LS) BMD in the long-term group further increased by 2.0% (12.1% increase vs. FREEDOM baseline at 48 months), and total hip (TH) BMD further increased by 0.8% (6.5% increase at 48 months) (p<0.0001 for both BMD gains during year 4; Fig. 1). During the first year of the extension, LS and TH BMD increased by 5.4% and 3.0%, respectively in the de novo group (both p<0.0001). After DMAb initiation, serum C-telopeptide (CTX) in the de novo group decreased rapidly and similarly to the long-term group (Fig. 2). Reductions in BTMs continue to attenuate at the end of the dosing interval as previously reported. Adverse event (AE) rates were similar (70.4% of women in the longterm group and 67.9% in the de novo group). Serious Aes were also similar (9.8% and 11.2% of women, respectively). During year 4, osteoporotic nonvertebral fractures were reported in 31 women in the long-term group and 51 in the denovo group.Fig. 1. Percentage change in BMD with denosumab for4 years (long-term) or 1 year (de novo)Fig. 2. Percentage change in sCTX over timeConclusions: These interim results suggest that continuation of DMAb treatment through 48 months is associated with further significant increases in spine and hip BMD with sustained reduction of bone turnover. The de-novo treatment group results confirm the first year active treatment findings previously reported1.Acknowledgements: Amgen Inc. sponsored this study. Figure ©2010, American Society for Bone and Mineral Research, used by permission, all rights reserved. Disclosure of Interest: H. Bone Grant/Research Support from: Amgen, Eli Lilly, Merck, Nordic Bioscience, Novartis, Takeda Pharmaceuticals, Consultant/Speaker's bureau/ Advisory activities with: Amgen, Merck, Takeda Pharmaceuticals, Zelos, S. Papapoulos Consultant/Speaker's bureau/ Advisory activities with: Amgen, Merck, Novartis, Lilly, Procter and Gamble, GSK, M.-L. Brandi Grant/Research Support from: MSD, GSK, Nycomed, NPS, Amgen, J. Brown Grant/Research Support from: Abbott, Amgen, Bristol Myers Squibb, Eli Lilly, Pfizer, Roche, Consultant/ Speaker's bureau/Advisory activities with: Abbott, Amgen, Eli Lilly, Novartis, Merck, Warner Chilcott,, R. Chapurlat Grant/Research Support from: Servier, Sanofi-Aventis, Warner-Chilcott, Novartis, Merck, Consultant/Speaker's bureau/Advisory activities with: Servier, Novartis, Amgen, E. Czerwinski: None Declared, N. Daizadeh Employee of: Amgen Inc., Stock ownership or royalties of: Amgen Inc., A. Grauer Employee of: Amgen Inc., Stock ownership or royalties of: Amgen Inc., C. Haller Employee of: Amgen Inc., Stock ownership or royalties of: Amgen Inc., M.-A. Krieg: None Declared, C. Libanati Employee of: Amgen Inc., Stock ownership or royalties of: Amgen Inc., Z. Man Grant/Research Support from: Amgen, D. Mellström: None Declared, S. Radominski Grant/Research Support from: Amgen, Pfizer, Roche, BMS, J.-Y. Reginster Grant/Research Support from: Bristol Myers Squibb, Merck Sharp & Dohme, Rottapharm, Teva, Lilly, Novartis, Roche, GlaxoSmithKline, Amgen, Servier, Consultant/Speaker's bureau/ Advisory activities with: Servier, Novartis, Negma, Lilly,Wyeth, Amgen, GlaxoSmithKline, Roche, Merckle, Nycomed, NPS, Theramex, UCB, Merck, Sharpe & Dohme, Rottapharm, IBSA, Genvrier, Teijin, Teva, Ebewee Pharma, Zodiac, Analis, Theramex, Novo-Nordisk, H. Resch: None Declared, J. A. Román Grant/Research Support from: Roche, Pharma, C. Roux Grant/Research Support from: Amgen, MSD, Novartis, Servier, Roche, Consultant/ Speaker's bureau/Advisory activities with: Amgen, MSD, Novartis, Servier, Roche, S. Cummings Grant/ Research Support from: Amgen, Lilly, Consultant/Speaker's bureau/Advisory activities with: Amgen, Lilly, Novartis, Merck

Peritalar dislocations: a retrospective study of 18 cases.

The purpose of this study is to retrospectively evaluate 18 consecutive cases of peritalar dislocations referred to our department during a period of 25 years and to delineate the factors influencing long-term prognosis. There were 13 (73%) medial and 5 (27%) lateral dislocations. Six patients (33%) suffered an open injury, including 2 of 13 (15%) medial and 4 of 5 (80%) lateral dislocations. Associated fractures involving the hindfoot or forefoot were noted in 7 feet, including 3 of 5 lateral dislocation cases. Reduction was accomplished under general anesthesia; in no case was open reduction necessary. In 4 of 6 open injuries with associated fractures, temporary fixation with Kirschner wires was performed. Patients were immobilized in a plaster cast for 4 weeks, or for 6 weeks in the presence of fracture, followed by weightbearing as tolerated. At a mean follow-up of 10.2 years (range, 4 to 26 years), 10 patients (56%) showed excellent results; all had sustained a closed medial low-energy dislocation. There were 3 cases (17%) with fair results and 5 cases (28%) with poor results. Forty-five percent of patients showed a restriction of activity, a reduction of subtalar range of motion, and moderate or severe radiographic signs of hindfoot degenerative arthritis. There were no cases of talar avascular necrosis, and in no case was secondary surgery necessary. Lateral dislocation and open medial dislocations with concomitant fractures showed a greater potential for poor prognosis. The results were independent from period of cast immobilization, suggesting that 4 to 6 weeks of immobilization provides acceptable long-term results.